A detailed history of Gf Fund Management Co. Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,348 shares of CRL stock, worth $226,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,348
Previous 1,222 10.31%
Holding current value
$226,207
Previous $185 Million 13.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$145.57 - $178.99 $18,341 - $22,552
126 Added 10.31%
1,348 $211 Million
Q2 2025

Jul 21, 2025

SELL
$99.75 - $151.89 $897 - $1,367
-9 Reduced 0.73%
1,222 $185 Million
Q4 2024

Feb 18, 2025

BUY
$178.58 - $220.69 $219,831 - $271,669
1,231 New
1,231 $227 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.